GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2016-2024
KEY FINDINGS
The global allergy diagnostic and treatment market is expected to grow at a CAGR of 5.5% for the forecast period of 2016-2024. The potential growth of this market has increased because of various factors such as increase in the occurrenceof allergies globally, higher percentage of urbanization and an increase in healthcare awareness and expenditure.
MARKET INSIGHTS
The various diagnostic tools for allergy testing are skin pricks,provocation testing, subcutaneous or patch analysis or blood analysis. On the basis of the type of tests performed, the global allergy diagnostic and treatment market is divided into skin testing and antibody testing. However, skin testing is proving its dominance in the market because of its quick effectiveness in identifying the allergen affecting the patient as compared to the antibody testing assay which is only used when the patient is on any medication which might interfere with the result of the skin tests. On the basis of the mode of availability for treatment, the market is divided as prescription and over the counter (OTC) with consumers inclining more to the OTC’s as they offer a quicker relief in relieving symptoms as compared to prescriptions and generic medications.
REGIONAL INSIGHTS
The Americas (mainly Brazil in South America and U.S in Central America) is expected to show its dominance in the global allergy diagnostic and treatment market during the forecast period as compared to Europe, Asia-Pacific and Rest of World. The main driving factors for this region are the increasing in the prevalence of allergic diseases, increasing population and rising pollution levels.
COMPETITIVE INSIGHTS
The major companies in the allergy diagnostics market are Thermo Fisher Scientific Inc, Lincoln Diagnostics Inc, Hitachi Chemical Diagnostics Inc., Danaher Corporation, Siemens AG, HYCOR Biomedical, and Stallergenes Greer. The rise in allergic diseases, increase in access and expenditure for medical insurance in the U.S coupled with economic growth in developing countries, easy access to healthcare by individuals and the availability of better diagnostic tools for allergy related problems are all acting as a driving force for this global allergy diagnostic and treatment market.
The global allergy diagnostic and treatment market is expected to grow at a CAGR of 5.5% for the forecast period of 2016-2024. The potential growth of this market has increased because of various factors such as increase in the occurrenceof allergies globally, higher percentage of urbanization and an increase in healthcare awareness and expenditure.
MARKET INSIGHTS
The various diagnostic tools for allergy testing are skin pricks,provocation testing, subcutaneous or patch analysis or blood analysis. On the basis of the type of tests performed, the global allergy diagnostic and treatment market is divided into skin testing and antibody testing. However, skin testing is proving its dominance in the market because of its quick effectiveness in identifying the allergen affecting the patient as compared to the antibody testing assay which is only used when the patient is on any medication which might interfere with the result of the skin tests. On the basis of the mode of availability for treatment, the market is divided as prescription and over the counter (OTC) with consumers inclining more to the OTC’s as they offer a quicker relief in relieving symptoms as compared to prescriptions and generic medications.
REGIONAL INSIGHTS
The Americas (mainly Brazil in South America and U.S in Central America) is expected to show its dominance in the global allergy diagnostic and treatment market during the forecast period as compared to Europe, Asia-Pacific and Rest of World. The main driving factors for this region are the increasing in the prevalence of allergic diseases, increasing population and rising pollution levels.
COMPETITIVE INSIGHTS
The major companies in the allergy diagnostics market are Thermo Fisher Scientific Inc, Lincoln Diagnostics Inc, Hitachi Chemical Diagnostics Inc., Danaher Corporation, Siemens AG, HYCOR Biomedical, and Stallergenes Greer. The rise in allergic diseases, increase in access and expenditure for medical insurance in the U.S coupled with economic growth in developing countries, easy access to healthcare by individuals and the availability of better diagnostic tools for allergy related problems are all acting as a driving force for this global allergy diagnostic and treatment market.
1. RESEARCH SCOPE
1.1. MARKET DEFINITION
1.2. STUDY GOALS
1.3. SCOPE OF THE MARKET STUDY
1.4. WHO WILL FIND THIS REPORT USEFUL?
1.5. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. PRIMARY SOURCES
2.1.2. SECONDARY SOURCES
2.2. MARKET SIZE ESTIMATION
2.3. DATA TRIANGULATION
2.4. ASSUMPTIONS
3. EXECUTIVE SUMMARY
3.1. INTRODUCTION
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES
4.1.2. RISING ENVIRONMENTAL POLLUTION
4.1.3. INCREASING HEALTHCARE EXPENDITURE
4.1.4. INCREASE IN ACCESS TO MEDICAL INSURANCE IN THE U.S.
4.2. MARKET RESTRAINTS
4.2.1. STRINGENT REGULATIONS FOR MEDICAL DEVICES
4.2.2. LACK OF AWARENESS ABOUT ALLERGIC DISEASES
4.2.3. HIGH CAPITAL REQUIREMENTS
4.2.4. HIGH DEGREE OF CONSOLIDATION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS
4.3. MARKET OPPORTUNITIES
4.3.1. ASIAN MARKET PRESENTS HIGH-GROWTH OPPORTUNITIES
5. DEVELOPMENTS IN ALLERGY TESTING AND TREATMENT
5.1. NEW DEVELOPMENTS IN DIAGNOSTIC TESTING
5.2. ALLERGEN COMPONENT-RESOLVED DIAGNOSTICS
5.3. ADVANCES IN TREATMENTS
5.3.1. CHINESE HERBAL MEDICINE
5.3.2. IMMUNOTHERAPY
5.3.3. B CELL EPITOPE-BASED IMMUNOTHERAPY
5.3.4. NASAL FILTERS
6. MARKET SEGMENTATION
6.1. GLOBAL ALLERGY DIAGNOSTIC MARKET, BY TYPE OF TEST
6.1.1. SKIN TESTING
6.1.2. ANTIBODY
6.2. GLOBAL IMMUNOTHERAPY MARKET, BY MODE OF ADMINISTRATION
6.2.1. SUBCUTANEOUS ADMINISTRATION
6.2.2. SUBLINGUAL LIQUID SOLUTIONS
6.2.3. SUBLINGUAL TABLETS
6.3. GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF AVAILABILITY
6.3.1. PRESCRIPTION
6.3.2. OVER THE COUNTER (OTC)
6.4. GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF ADMINISTRATION
6.4.1. ORAL
6.4.2. SPRAY
6.4.3. OCULAR
6.4.4. TOPICAL
6.5. GLOBAL ALLERGY TREATMENT MARKET, BY PRODUCT
6.5.1. ANTIHISTAMINES
6.5.2. SYMPATHOMIMETICS, DECONGESTANTS, AND COMBINATIONS
6.5.3. CORTICOSTEROIDS
6.5.4. LEUKOTRIENES
6.5.5. MAST CELL STABILIZERS
7. KEY ANALYTICS
7.1. PORTER’S FIVE FORCES
7.2. PESTEL ANALYSIS
7.3. OPPORTUNITY MATRIX
8. GEOGRAPHICAL ANALYSIS
8.1. AMERICAS
8.1.1. UNITED STATES
8.1.2. CANADA
8.1.3. BRAZIL
8.2. EUROPE
8.2.1. GERMANY
8.2.2. FRANCE
8.2.3. UK
8.2.4. RUSSIA
8.2.5. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. INDIA
8.3.2. CHINA
8.3.3. JAPAN
8.3.4. AUSTRALIA AND NEW ZEALAND
8.3.5. REST OF ASIA-PACIFIC (ROAPAC)
8.4. MIDDLE EAST & AFRICA
9. COMPETITIVE ANALYSIS
9.1. MARKET SHARE
9.2. COMPANY PROFILES FOR DIAGNOSTICS
9.2.1. ALERE
9.2.2. ALK-ABELLÓ
9.2.3. ALLERGY LABORATORIES INC.
9.2.4. ALLERGOPHARMA AG
9.2.5. ANI BIOTECHNOLOGY
9.2.6. BECKMAN COULTER/DANAHER
9.2.7. BIOMERICA
9.2.8. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
9.2.9. FIRST DIAGNOSTIC LLC
9.2.10. GREER HUMAN ALLERGY
9.2.11. HAL ALLERGY
9.2.12. HOLLISTER-STIER ALLERGY
9.2.13. HITACHI CHEMICAL DIAGNOSTICS INC.
9.2.14. HYCOR BIOMEDICAL
9.2.15. LABCORP OF AMERICA
9.2.16. LINCOLN DIAGNOSTICS
9.2.17. QUEST DIAGNOSTICS
9.2.18. SIEMENS HEALTHCARE
9.2.19. SMARTPRACTICE DENMARK
9.2.20. TERUMO MEDICAL PRODUCTS
9.2.21. THERMO FISHER DIAGNOSTICS (IMMUNODIAGNOSTICS)
9.3. COMPANY PROFILES FOR TREATMENT
9.3.1. ALCON LABORATORIES
9.3.2. ALK-ABELLÓ
9.3.3. ALLERGEN PHARMACEUTICALS
9.3.4. AMEDRA PHARMACEUTICALS LLC
9.3.5. AQUA PHARMACEUTICALS
9.3.6. FERNDALE PHARMA GROUP (FERNDALE HEALTHCARE)
9.3.7. GALDERMA S.A.
9.3.8. GLAXOSMITHKLINE
9.3.9. JOHNSON & JOHNSON
9.3.10. KYOWA HAKKO KIRIN PHARMA INC.
9.3.11. LUPIN LTD.
9.3.12. MEDA AB
9.3.13. MERCK
9.3.14. MYLAN INC.
9.3.15. PFIZER
9.3.16. PIERRE FABRE MEDICAMENT
9.3.17. RANBAXY LABORATORIES
9.3.18. ROCHE
9.3.19. SANDOZ INTERNATIONAL GMBH
9.3.20. SANOFI
9.3.21. STALLERGENES AS
9.3.22. TARO PHARMACEUTICAL INDUSTRIES
9.3.23. UCB PHARMA LTD.
10. APPENDIX
10.1. PATENTS
10.2. ABBREVIATIONS AND FULL FORM
TABLE LIST
TABLE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $BILLION)
TABLE 2 GLOBAL SKIN TESTING MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 3 GLOBAL ANTIBODIES MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 4 GLOBAL SUB-CUTANEOUS ADMINISTRATION MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 5 GLOBAL SUBLINGUAL LIQUID SOLUTIONS MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 6 GLOBAL SUBLINGUAL TABLETS MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 7 GLOBAL PRESCRIPTION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 8 GLOBAL OVER THE COUNTER PRODUCTS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 9 GLOBAL ORAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 10 GLOBAL ADMINISTRATION BY SPRAY MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 11 GLOBAL OCULAR ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 12 GLOBAL TOPICAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 13 GLOBAL ANTIHISTAMINES MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 14 GLOBAL SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 15 GLOBAL CORTICOSTEROIDS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 16 GLOBAL LEUKOTRIENES MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 17 GLOBAL MAST CELL STABILIZERS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
FIGURE LIST
FIGURE 1 MARKET SIZE ESTIMATION
FIGURE 2 DATA TRIANGULATION
FIGURE 3 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $BILLION)
FIGURE 4 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET SHARE, 2016
FIGURE 5 GLOBAL ALLERGY DIAGNOSTIC MARKET SHARE, BY TYPE OF TEST, 2016
FIGURE 6 GLOBAL SKIN TESTING MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 7 GLOBAL ANTIBODIES MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 8 GLOBAL IMMUNOTHERAPY MARKET SHARE, BY MODE OF ADMINISTRATION, 2016
FIGURE 9 GLOBAL SUB-CUTANEOUS ADMINISTRATION MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 10 GLOBAL SUBLINGUAL LIQUID SOLUTIONS MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 11 GLOBAL SUBLINGUAL TABLETS MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 12 GLOBAL ALLERGY TREATMENT MARKET SHARE, BY MODE OF AVAILABILITY, 2016
FIGURE 13 GLOBAL PRESCRIPTION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 14 GLOBAL OVER THE COUNTER PRODUCTS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 15 GLOBAL ALLERGY TREATMENT MARKET SHARE, BY MODE OF ADMINISTRATION, 2016
FIGURE 16 GLOBAL ORAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 17 GLOBAL ADMINISTRATION BY SPRAY MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 18 GLOBAL OCULAR ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 19 GLOBAL TOPICAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 20 GLOBAL ALLERGY TREATMENT MARKET SHARE, BY PRODUCT, 2016
FIGURE 21 GLOBAL ANTIHISTAMINES MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 22 GLOBAL SYMPATHOMIMETICS, DECONGESTANTS, AND COMBINATIONS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 23 GLOBAL CORTICOSTEROIDS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 24 GLOBAL LEUKOTRIENES MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 25 GLOBAL MAST CELL STABILIZERS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 26 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET SHARE, BY REGION, 2016
FIGURE 27 AMERICAS ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 28 UNITED STATES ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 29 CANADA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 30 BRAZIL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 31 EUROPE, MIDDLE EAST, AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 32 EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 33 GERMANY ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 34 FRANCE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 35 UK ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 36 RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 37 ROE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 38 ASIA-PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024 (IN $BILLION)
FIGURE 39 INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 40 CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 41 JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 42 AUSTRALIA AND NEW ZEALAND ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 43 REST OF ASIA-PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 44 MIDDLE EAST ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 45 AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
1.1. MARKET DEFINITION
1.2. STUDY GOALS
1.3. SCOPE OF THE MARKET STUDY
1.4. WHO WILL FIND THIS REPORT USEFUL?
1.5. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. PRIMARY SOURCES
2.1.2. SECONDARY SOURCES
2.2. MARKET SIZE ESTIMATION
2.3. DATA TRIANGULATION
2.4. ASSUMPTIONS
3. EXECUTIVE SUMMARY
3.1. INTRODUCTION
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES
4.1.2. RISING ENVIRONMENTAL POLLUTION
4.1.3. INCREASING HEALTHCARE EXPENDITURE
4.1.4. INCREASE IN ACCESS TO MEDICAL INSURANCE IN THE U.S.
4.2. MARKET RESTRAINTS
4.2.1. STRINGENT REGULATIONS FOR MEDICAL DEVICES
4.2.2. LACK OF AWARENESS ABOUT ALLERGIC DISEASES
4.2.3. HIGH CAPITAL REQUIREMENTS
4.2.4. HIGH DEGREE OF CONSOLIDATION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS
4.3. MARKET OPPORTUNITIES
4.3.1. ASIAN MARKET PRESENTS HIGH-GROWTH OPPORTUNITIES
5. DEVELOPMENTS IN ALLERGY TESTING AND TREATMENT
5.1. NEW DEVELOPMENTS IN DIAGNOSTIC TESTING
5.2. ALLERGEN COMPONENT-RESOLVED DIAGNOSTICS
5.3. ADVANCES IN TREATMENTS
5.3.1. CHINESE HERBAL MEDICINE
5.3.2. IMMUNOTHERAPY
5.3.3. B CELL EPITOPE-BASED IMMUNOTHERAPY
5.3.4. NASAL FILTERS
6. MARKET SEGMENTATION
6.1. GLOBAL ALLERGY DIAGNOSTIC MARKET, BY TYPE OF TEST
6.1.1. SKIN TESTING
6.1.2. ANTIBODY
6.2. GLOBAL IMMUNOTHERAPY MARKET, BY MODE OF ADMINISTRATION
6.2.1. SUBCUTANEOUS ADMINISTRATION
6.2.2. SUBLINGUAL LIQUID SOLUTIONS
6.2.3. SUBLINGUAL TABLETS
6.3. GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF AVAILABILITY
6.3.1. PRESCRIPTION
6.3.2. OVER THE COUNTER (OTC)
6.4. GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF ADMINISTRATION
6.4.1. ORAL
6.4.2. SPRAY
6.4.3. OCULAR
6.4.4. TOPICAL
6.5. GLOBAL ALLERGY TREATMENT MARKET, BY PRODUCT
6.5.1. ANTIHISTAMINES
6.5.2. SYMPATHOMIMETICS, DECONGESTANTS, AND COMBINATIONS
6.5.3. CORTICOSTEROIDS
6.5.4. LEUKOTRIENES
6.5.5. MAST CELL STABILIZERS
7. KEY ANALYTICS
7.1. PORTER’S FIVE FORCES
7.2. PESTEL ANALYSIS
7.3. OPPORTUNITY MATRIX
8. GEOGRAPHICAL ANALYSIS
8.1. AMERICAS
8.1.1. UNITED STATES
8.1.2. CANADA
8.1.3. BRAZIL
8.2. EUROPE
8.2.1. GERMANY
8.2.2. FRANCE
8.2.3. UK
8.2.4. RUSSIA
8.2.5. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. INDIA
8.3.2. CHINA
8.3.3. JAPAN
8.3.4. AUSTRALIA AND NEW ZEALAND
8.3.5. REST OF ASIA-PACIFIC (ROAPAC)
8.4. MIDDLE EAST & AFRICA
9. COMPETITIVE ANALYSIS
9.1. MARKET SHARE
9.2. COMPANY PROFILES FOR DIAGNOSTICS
9.2.1. ALERE
9.2.2. ALK-ABELLÓ
9.2.3. ALLERGY LABORATORIES INC.
9.2.4. ALLERGOPHARMA AG
9.2.5. ANI BIOTECHNOLOGY
9.2.6. BECKMAN COULTER/DANAHER
9.2.7. BIOMERICA
9.2.8. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
9.2.9. FIRST DIAGNOSTIC LLC
9.2.10. GREER HUMAN ALLERGY
9.2.11. HAL ALLERGY
9.2.12. HOLLISTER-STIER ALLERGY
9.2.13. HITACHI CHEMICAL DIAGNOSTICS INC.
9.2.14. HYCOR BIOMEDICAL
9.2.15. LABCORP OF AMERICA
9.2.16. LINCOLN DIAGNOSTICS
9.2.17. QUEST DIAGNOSTICS
9.2.18. SIEMENS HEALTHCARE
9.2.19. SMARTPRACTICE DENMARK
9.2.20. TERUMO MEDICAL PRODUCTS
9.2.21. THERMO FISHER DIAGNOSTICS (IMMUNODIAGNOSTICS)
9.3. COMPANY PROFILES FOR TREATMENT
9.3.1. ALCON LABORATORIES
9.3.2. ALK-ABELLÓ
9.3.3. ALLERGEN PHARMACEUTICALS
9.3.4. AMEDRA PHARMACEUTICALS LLC
9.3.5. AQUA PHARMACEUTICALS
9.3.6. FERNDALE PHARMA GROUP (FERNDALE HEALTHCARE)
9.3.7. GALDERMA S.A.
9.3.8. GLAXOSMITHKLINE
9.3.9. JOHNSON & JOHNSON
9.3.10. KYOWA HAKKO KIRIN PHARMA INC.
9.3.11. LUPIN LTD.
9.3.12. MEDA AB
9.3.13. MERCK
9.3.14. MYLAN INC.
9.3.15. PFIZER
9.3.16. PIERRE FABRE MEDICAMENT
9.3.17. RANBAXY LABORATORIES
9.3.18. ROCHE
9.3.19. SANDOZ INTERNATIONAL GMBH
9.3.20. SANOFI
9.3.21. STALLERGENES AS
9.3.22. TARO PHARMACEUTICAL INDUSTRIES
9.3.23. UCB PHARMA LTD.
10. APPENDIX
10.1. PATENTS
10.2. ABBREVIATIONS AND FULL FORM
TABLE LIST
TABLE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $BILLION)
TABLE 2 GLOBAL SKIN TESTING MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 3 GLOBAL ANTIBODIES MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 4 GLOBAL SUB-CUTANEOUS ADMINISTRATION MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 5 GLOBAL SUBLINGUAL LIQUID SOLUTIONS MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 6 GLOBAL SUBLINGUAL TABLETS MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)
TABLE 7 GLOBAL PRESCRIPTION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 8 GLOBAL OVER THE COUNTER PRODUCTS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 9 GLOBAL ORAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 10 GLOBAL ADMINISTRATION BY SPRAY MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 11 GLOBAL OCULAR ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 12 GLOBAL TOPICAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 13 GLOBAL ANTIHISTAMINES MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 14 GLOBAL SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 15 GLOBAL CORTICOSTEROIDS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 16 GLOBAL LEUKOTRIENES MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
TABLE 17 GLOBAL MAST CELL STABILIZERS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
FIGURE LIST
FIGURE 1 MARKET SIZE ESTIMATION
FIGURE 2 DATA TRIANGULATION
FIGURE 3 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $BILLION)
FIGURE 4 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET SHARE, 2016
FIGURE 5 GLOBAL ALLERGY DIAGNOSTIC MARKET SHARE, BY TYPE OF TEST, 2016
FIGURE 6 GLOBAL SKIN TESTING MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 7 GLOBAL ANTIBODIES MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 8 GLOBAL IMMUNOTHERAPY MARKET SHARE, BY MODE OF ADMINISTRATION, 2016
FIGURE 9 GLOBAL SUB-CUTANEOUS ADMINISTRATION MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 10 GLOBAL SUBLINGUAL LIQUID SOLUTIONS MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 11 GLOBAL SUBLINGUAL TABLETS MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)
FIGURE 12 GLOBAL ALLERGY TREATMENT MARKET SHARE, BY MODE OF AVAILABILITY, 2016
FIGURE 13 GLOBAL PRESCRIPTION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 14 GLOBAL OVER THE COUNTER PRODUCTS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 15 GLOBAL ALLERGY TREATMENT MARKET SHARE, BY MODE OF ADMINISTRATION, 2016
FIGURE 16 GLOBAL ORAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 17 GLOBAL ADMINISTRATION BY SPRAY MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 18 GLOBAL OCULAR ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 19 GLOBAL TOPICAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 20 GLOBAL ALLERGY TREATMENT MARKET SHARE, BY PRODUCT, 2016
FIGURE 21 GLOBAL ANTIHISTAMINES MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 22 GLOBAL SYMPATHOMIMETICS, DECONGESTANTS, AND COMBINATIONS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 23 GLOBAL CORTICOSTEROIDS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 24 GLOBAL LEUKOTRIENES MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 25 GLOBAL MAST CELL STABILIZERS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)
FIGURE 26 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET SHARE, BY REGION, 2016
FIGURE 27 AMERICAS ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 28 UNITED STATES ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 29 CANADA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 30 BRAZIL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 31 EUROPE, MIDDLE EAST, AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 32 EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 33 GERMANY ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 34 FRANCE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 35 UK ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 36 RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 37 ROE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 38 ASIA-PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024 (IN $BILLION)
FIGURE 39 INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 40 CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 41 JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 42 AUSTRALIA AND NEW ZEALAND ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 43 REST OF ASIA-PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 44 MIDDLE EAST ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
FIGURE 45 AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
